Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer

Autor: Tan, E.H. *, Rolski, J., Grodzki, T., Schneider, C.P., Gatzemeier, U. 5, Zatloukal, P. 6, Aitini, E. 7, Carteni, G. 8, Riska, H. 9, Tsai, Y.H. 10, Abratt, R. 11
Zdroj: In Annals of Oncology July 2009 20(7):1249-1256
Databáze: ScienceDirect